Emergent BioSolutions (EBS) Cash from Operations (2010 - 2026)
Emergent BioSolutions (EBS) posted quarterly Cash from Operations of 33800000.0 for Q1 2026, down 201.79% year-over-year from 33207017.54 in Q1 2025, and down 143.5% quarter-over-quarter from 77700000.0 in Q4 2025.
Emergent BioSolutions (EBS) Cash from Operations (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Cash from Operations history runs 17 years deep, the most recent figure standing at 33800000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 201.79% year-over-year to 33800000.0; the TTM figure through Mar 2026 stood at 148000000.0 (up 34.42% YoY), while the FY2025 annual figure was 170600000.0, up 190.63% from the prior year.
- Cash from Operations for Q1 2026 stood at 33800000.0, down from 77700000.0 in the prior quarter.
- The five-year high for Cash from Operations was 153700000.0 in Q3 2024, with the low at 184000000.0 in Q1 2023.
- The 5-year median for Cash from Operations is 11200000.0 (2025), against an average of 2641176.47.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations slumped 831.37% in 2022, then surged 197.25% in 2025.
- Emergent BioSolutions' Cash from Operations stood at 92800000.0 in 2022, then tumbled by 65.41% to 32100000.0 in 2023, then sank by 348.91% to 79900000.0 in 2024, then soared by 197.25% to 77700000.0 in 2025, then slumped by 143.5% to 33800000.0 in 2026.
- Business Quant data shows EBS's Cash from Operations at 33800000.0 in Q1 2026, 77700000.0 in Q4 2025, and 2300000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 253.61 Mn | 112.71 Mn | 137.20 Mn | 56.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.10 Mn |
| Jun 30, 2026 | 56.10 Mn |
| Mar 31, 2026 | -33.80 Mn |
| Mar 31, 2026 | -33.80 Mn |
| Dec 31, 2025 | 77.70 Mn |
| Dec 31, 2025 | 77.70 Mn |
| Sep 30, 2025 | -2.30 Mn |
| Sep 30, 2025 | -2.30 Mn |
| Jun 30, 2025 | 106.40 Mn |
| Jun 30, 2025 | 106.40 Mn |
| Mar 31, 2025 | -11.20 Mn |
| Mar 31, 2025 | -11.20 Mn |
| Dec 31, 2024 | -79.90 Mn |
| Dec 31, 2024 | -79.90 Mn |
| Sep 30, 2024 | 153.70 Mn |
| Sep 30, 2024 | 153.70 Mn |
| Jun 30, 2024 | 47.50 Mn |
| Jun 30, 2024 | 47.50 Mn |
| Mar 31, 2024 | -62.60 Mn |
| Mar 31, 2024 | -62.60 Mn |